Affiliations
AffiliationsItem in Clipboard
Age, margin status, high-risk human papillomavirus and cytology independently predict recurrent high-grade cervical intraepithelial neoplasia up to 6 years after treatmentSonia Andersson et al. Oncol Lett. 2021 Sep.
doi: 10.3892/ol.2021.12945. Epub 2021 Jul 27. AffiliationsItem in Clipboard
AbstractThe present study aimed to identify the factors that independently contribute to disease recurrence among women first-time treated for high-grade cervical intraepithelial neoplasia (CIN) during 4-6 years of follow-up. Overall, 529 of 530 eligible patients participated; these patients all attended a 1st follow-up appointment ~6 months post-conization, at which time high-risk human-papillomavirus (HPV) testing, liquid-based cytology and colposcopy were performed. Full data on margin excision status, other aspects of initial treatment and comorbidity were obtained. At least one subsequent follow-up was attended by 88% of patients. A total of 22 recurrent cases were detected during follow-up. Detected recurrence was the outcome of focus for multiple logistic regression analysis, with odds ratios (OR) and 95% confidence intervals (CI) computed. Four significant independent risk factors were identified: Age 45 years or above (OR=3.5, 95% CI=1.3-9.9), one or both unclear or uncertain margins (OR=5.3, 95% CI=2.0-14.2), positive HPV at 1st follow-up (OR=5.8, 95% CI=2.0-16.8), and abnormal cytology at 1st follow-up (OR=3.9, 95% CI=1.4-11.0). Bivariate analysis revealed that persistent HPV positivity was associated with recurrence (P<0.01). These findings indicated that incomplete excision of the CIN lesion may warrant more intensive subsequent screening, regardless of early post-conization HPV findings. Although early post-conization positive HPV was a powerful, independent predictor of recurrent high-grade CIN, over one-third of the patients with detected recurrence had a negative early post-conization HPV finding. These patients returned for routine screening, at which time, in most cases, HPV status was positive, thus indicating the need for repeated HPV evaluation. Especially during the on-going pandemic, home vaginal self-sampling is recommended. Particular attention is required for women aged ≥45 years. In addition, although not statistically significant, relevant comorbidities, especially autoimmune conditions, warrant consideration in clinical decision-making. Women who have been treated for high-grade CIN are at risk for recurrent disease and progression to cervical cancer; therefore, they require careful, individualized follow-up to avoid these adverse consequences.
Keywords: age; cervical intraepithelial neoplasia; margin status; papillomavirus infection; treatment failure.
Copyright: © Andersson et al.
Conflict of interest statementThe authors declare that they have no competing interests.
FiguresFigure 1.
Flow chart of how the…
Figure 1.
Flow chart of how the patients were triaged. The shaded rectangles highlight the…
Figure 1.Flow chart of how the patients were triaged. The shaded rectangles highlight the patients in whom recurrence was detected in relation to the follow-up procedures. HPV, high-risk human papillomavirus.
Similar articlesFan A, Wang C, Han C, Wang Y, Xue F, Zhang L. Fan A, et al. J Med Virol. 2018 Sep;90(9):1541-1548. doi: 10.1002/jmv.25208. Epub 2018 May 25. J Med Virol. 2018. PMID: 29704442
Östensson E, Belkić K, Ramqvist T, Mints M, Andersson S. Östensson E, et al. Oncol Lett. 2021 Apr;21(4):240. doi: 10.3892/ol.2021.12501. Epub 2021 Jan 31. Oncol Lett. 2021. PMID: 33664804 Free PMC article.
Kamio M, Yanazume S, Togami S, Kobayashi H. Kamio M, et al. J Obstet Gynaecol India. 2021 Feb;71(1):66-71. doi: 10.1007/s13224-020-01368-8. Epub 2020 Sep 10. J Obstet Gynaecol India. 2021. PMID: 33814801 Free PMC article.
Zhao C, Hong W, Li Z, Weng B, Amin M, Austin RM. Zhao C, et al. J Am Soc Cytopathol. 2014 Jan-Feb;3(1):15-20. doi: 10.1016/j.jasc.2013.09.004. Epub 2013 Oct 22. J Am Soc Cytopathol. 2014. PMID: 31051725
Hamar B, Teutsch B, Hoffmann E, Hegyi P, Harnos A, Nyirády P, Hunka Z, Ács N, Bánhidy F, Melczer Z. Hamar B, et al. Cancers (Basel). 2024 Apr 22;16(8):1610. doi: 10.3390/cancers16081610. Cancers (Basel). 2024. PMID: 38672691 Free PMC article. Review.
Tian Q, Ma J, Wu Y, Wang L, Yang W. Tian Q, et al. Open Med (Wars). 2025 Mar 6;20(1):20241101. doi: 10.1515/med-2024-1101. eCollection 2025. Open Med (Wars). 2025. PMID: 40061832 Free PMC article.
Scherer-Quenzer AC, Findeis J, Herbert SL, Yokendren N, Reinhold AK, Schlaiss T, Wöckel A, Diessner J, Kiesel M. Scherer-Quenzer AC, et al. BMC Womens Health. 2024 Aug 21;24(1):461. doi: 10.1186/s12905-024-03291-w. BMC Womens Health. 2024. PMID: 39169335 Free PMC article.
Zhang Y, Ni Z, Wei T, Liu Q. Zhang Y, et al. BMC Womens Health. 2023 May 3;23(1):216. doi: 10.1186/s12905-023-02360-w. BMC Womens Health. 2023. PMID: 37138261 Free PMC article.
Zhai F, Mu S, Song Y, Zhang M, Zhang C, Lv Z. Zhai F, et al. Int J Womens Health. 2024 Oct 30;16:1775-1787. doi: 10.2147/IJWH.S485515. eCollection 2024. Int J Womens Health. 2024. PMID: 39493663 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3